News | October 04, 2022
Moderna creates new executive committee role for product launches
Juan Andres Appointed to President, Strategic Partnerships and Enterprise Expansion
Juan Andres Appointed to President, Strategic Partnerships and Enterprise Expansion
The inspection of the facility was conducted from August 16-19, 2022.
In the next six months, the program aims to screen 4,000 women from underprivileged communities in and around Mathura
The combination of Optym, Emmes' ophthalmology certification unit, and Clinical Edge will make the organization a leader in ophthalmic certification and training services
Dr. Bunker will focus on leading Research and Development (R&D) in San Diego, advancing the preclinical pipeline and optimizing the Company’s Integrated Discovery Engine.
‘PathoDetect HPV Detection Test’ detects and discriminates the presence of high-risk HPV strains including 16 and 18 which cause most of the cervical cancers.
Funds raised will be used to develop technology and foster healthcare partnerships
The companies will leverage their respective proprietary technology platforms
This newly launched institute will be the centre of excellence in the treatment of all cancers under a single roof.
NULIBRY is a first-in-class cPMP substrate replacement therapy to reduce the risk of mortality in patients with MoCD Type A.
Subscribe To Our Newsletter & Stay Updated
